Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07451613 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

Name: Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease — clinical trial record (NCT07451613)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REGEN4HD

StatusRecruiting

PhasePhase 1/2

SponsorLeslie Thompson

Started2026-04-06

View on ClinicalTrials.gov ↗

Amendment history

2026-04-06

Study Status, Contacts/Locations v1

Recruitment opened

Start dateestimated 2026-03→confirmed 2026-04-06

Study sitesdetails revised at 1 of 1 site

2026-02-28

Original filing

Leslie Thompson

1 trial monitored

See all monitored trials

Huntington's Disease

78 trials monitored

See 3 trials at risk

The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.

Trial Details

NCT Number	NCT07451613
Lead Sponsor	Leslie Thompson Collaborators: California Institute for Regenerative Medicine (CIRM), University of California, Irvine
Conditions	Huntington Disease
Enrollment	21 participants
Start Date	2026-04-06
Primary Completion	2028-06 (estimated)
Study Completion	2031-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-13